Radiation and immune checkpoint inhibitor-mediated pneumonitis risk stratification in patients with locally advanced non-small cell lung cancer: role of functional lung radiomics?

BACKGROUND: Patients undergoing chemoradiation and immune checkpoint inhibitor (ICI) therapy for locally advanced non-small cell lung cancer (NSCLC) experience pulmonary toxicity at higher rates than historical reports. Identifying biomarkers beyond conventional clinical factors and radiation dosime...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Hannah M. T., Hippe, Daniel S., Forouzannezhad, Parisa, Sasidharan, Balu Krishna, Kinahan, Paul E., Miyaoka, Robert S., Vesselle, Hubert J., Rengan, Ramesh, Zeng, Jing, Bowen, Stephen R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437196/
https://www.ncbi.nlm.nih.gov/pubmed/36048266
http://dx.doi.org/10.1007/s12672-022-00548-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437196/
https://www.ncbi.nlm.nih.gov/pubmed/36048266
http://dx.doi.org/10.1007/s12672-022-00548-4

Ejemplares similares